Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology ... ( Chimeric Peptide Vaccine Aims to Use...)

HOME >> MEDICINE >> TECHNOLOGY

Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology Conference

Date:8/20/2007

Chimeric Peptide Vaccine Aims to Use Memory Imprint to Yield a Strong and

Highly Specific Immune Response

NEW YORK, Aug. 20 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (OTC Bulletin Board: ILNS) a biopharmaceutical company focused on development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and related disorders, announced today that Dr. Rachel Eren, Vice President Research, will present new data regarding the Company's RECALL-VAX(TM) chimeric peptide vaccine technology at the 13th International Congress of Immunology on Thursday, August 23, 2007 in Rio de Janeiro, Brazil. Mice immunized with RECALL-VAX(TM) constructs mounted a robust and highly specific immune response against beta-amyloid. The data demonstrate for the first time that a "free-end specific" polyclonal response to beta-amyloid can be achieved, potentially overcoming an important safety concern for active immunization of Alzheimer's disease patients.

"We are pleased with our scientists' progress in establishing important proof of principle for this novel and proprietary vaccine technology, which is designed to make active immunization safe and practical for treating Alzheimer's patients," commented Dr. Daniel Chain, Intellect's Chairman and CEO. He added: "We believe that RECALL-VAX(TM) could potentially be used prophylactically to prevent or delay the onset of Alzheimer's disease in elderly people."

"There are multiple challenges in developing a means to safely immunize elderly individuals and avoid the failures encountered in previous clinical trials sponsored by major pharmaceutical companies," commented Professor Benjamin Chain at the Department of Immunology and Molecular Pathology, Windeyer Institute of Medical Sciences, University College London. Professor Chain added: "The major challenges are the need to: (i) mount a robust immune response when the immune system has become senescent as
'/>"/>

SOURCE Intellect Neurosciences, Inc.

1

GOOD

Page: 1 2 3
Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:

(Date:11/9/2009)...9 Hologic, Inc. (Hologic...oper, manufacturer and supplier of premium diagnos...s dedicated to serving the healthcare needs of wom...rter and fiscal year ended September 26, 2009. In ...ectors has promoted Robert Cascella to Chief Execu...

(Date:11/9/2009)..., N.J., Nov. 9 Pharmasse... present at the Sixth Annual Lazard Capital Market...ld at the St Regis Hotel in New York City (Novembe... President and Chief Executive Officer, will provi...er 18, 2009 at 3:45 PM (ET). ,, To access a sim...

(Date:11/9/2009)...09 Arena Pharmaceuticals...esults for the third quarter ended September 30, 2...le to common stockholders in the third quarter of ...d to a net loss allocable to common stockholders i...0.76 per share, and a net loss allocable to common...

[0] Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results [0] Pharmasset to Present at Lazard Capital Markets Healthcare Conference [0] Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments

...ublic health, we need to fast-track research and a...if., Oct. 24 On the heels,of a study published th...ing science related to HPV and oral cancer in the ...oundation is urging researchers to,expedite invest...V),vaccinations for males, and the FDA to fast tra...

... EVEREST Patient Registry Presented at TCT 2007; E...t Continues, WASHINGTON, Oct. 24 The vast majori...e percutaneous MitraClip device did not need,mitra... and many benefited,from significantly improved fu...verse remodeling), according to data presented thi...

Other Medicine Technology:The Oral Cancer Foundation Urges HPV Vaccination for Males 2 The Oral Cancer Foundation Urges HPV Vaccination for Males 3 New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 2 New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 3 New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 4 New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation 5

The Oral Cancer Foundation Urges HPV Vaccination for Males New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation

(Date:11/9/2009)...etary Vilsack, Governor Patrick, and Lieutenant Go...Newswire/ -- In a groundbreaking move for antihung...r) called for all of the state,s hospitals to take...r care. ,, "With 554,000 people in Massachuset...ess conference at UMass Memorial Health Care in Wo...

(Date:11/9/2009)...PRNewswire-Asia-FirstCall/ -- Mindray Medical,Inte...r, manufacturer and,marketer of medical devices wo...nancial results for the third quarter and nine mon...or Operations as of September 30, 2009, -- Thir...n increase of, 3.1% over the third quarter o...

(Date:11/9/2009)...guage, Federal Trade Commission Involvement Need t... Inclusion of a provisi...H.R. 3962) allowing insurance agents to sell healt...s positive, but other issues remain to be addresse...tion of Professional Insurance Agents (PIA). ,,...

(Date:11/9/2009)...re/ -- Tracy Anderson, trainer to Gwyneth Paltrow,...sting two events at her LA studio this week that a...waited Nutritional Meal Plan and Delivery Service,...e and Lifestyle Menu. She will also be teaching a...of cardio and muscle structure work. Both events ...

(Date:11/9/2009)...equally, study finds, , , MONDAY, Nov. ...ing drug Plavix (clopidogrel) works about the same... trials has found. , "After this study, I can s...men with this very important drug," said Dr. Jeffr...s at New York University Langone Medical Center in...

[0] McGovern and Project Bread Launch Hospital Hunger Initiative [0] Mindray Announces Third Quarter 2009 Financial Results [0] PIA Says Inclusion of Agents in House Healthcare Bill is Positive, But Concerns Remain [0] Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week [0] No Gender Gap Found for Clot-Busting Drug

... with post traumatic stress disorder (PTSD) have s...f life according to research by Dr. J. Donald Rich...s co-investigators. , The research, published thi...ies just as much to peacekeeping veterans as to co...

...ast-Growth Companies to Quell Your Recession Fears... Nuclear Medicine Professionals, Inc. Ranks No. 46... 1161 on the Inc. 5000 With Three-Year Sales Growt...c.] on its annual ranking of the 5000 fastest-grow...

...Is Needed, Says Editor of "The Oncologist", DURHA...,a study supporting the use of computed tomography...in smokers and other people at risk, the,Editor-in... ), " ... the results of this key lung cancer pr...

... 1, 2008 is a landmark,day in Tennessee history. T...erm Care Partnership that rewards Tennesseans for ...y. By encouraging the purchase of long-term,care i...te Medicaid budget saves money., Tennessee joins ...

..., Inc.,(Nasdaq: THRM ), a leader in non-invasive ... announced that it will present at the 2008 Maxim ...n is scheduled for 10:00 a.m.,Eastern Time on Tues...inancial results., Attendance at the conference i...

... - Share Exchange Offer to the Holders of the Foll... ISIN: US4781601046 - Symbol: JNJ, The K&N Value ...ities,named above for every 1 Johnson & Johnson sh...th November,2008., K&N Value Select Corp. reserve...

Other Medicine News:Health News:Whether combat or peacekeeping, PTSD impacts veterans' well-being 2 Health News:America's 5000 Fastest-Growing Private Companies Revealed 2 Health News:New Questions Raised About Lung Cancer Screening 2 Health News:New Questions Raised About Lung Cancer Screening 3 Health News:Tennessee Introduces Long-Term Care Partnership Insurance Policies and Producer Training Requirement 2

Whether combat or peacekeeping, PTSD impacts veterans' well-being America's 5000 Fastest-Growing Private Companies Revealed New Questions Raised About Lung Cancer Screening Tennessee Introduces Long-Term Care Partnership Insurance Policies and Producer Training Requirement Thermage, Inc. to Present at the Maxim Group Growth Conference Johnson & Johnson Share Exchange Offer

...system from Del Mar Reynolds Medical. Available as...ergometer, PC, Cart, isolation transformer and a n...ct patient interface module that is used for resti... the CardioCollect as the patient interface module...

...diagnosis, the fully featured CH2000 Stress Test S...t measures T-wave alternans at the microvolt level...ol facility, this combines with the WAVESTAR ECG f... outstanding and noise-free ECG recordings with mi...

...ess system, the Quest, combines innovative touchsc...ilities. Combined with a 15" color monitor, users ... to program or select specific functions. Quest ev...ghting the step usually taken next. No more search...

...or makes refracting easier for you and your patien...rts in any order you wish, freeing you to conduct ...ng one button each time you want to move to the ne...random access gives you the option of performing a...

Medicine Products:

CardioDirect12-S Cambridge Heart CH2000 Stress-Test System Quest Exercise Stress System CP-690E Automated Projector

Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology ...( Chimeric Peptide Vaccine Aims to Use...),Health